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Streptococcus pneumoniae is a common human pathogen and a major causal agent of
life-threatening infections that can either be respiratory or non-respiratory. It is well known
that the Helix pomatia (edible snail) agglutinin (HPA) lectin shows specificity for terminal
αGalNAc residues present, among other locations, in the Forssman pentasaccharide
(αGalNAc1→3βGalNAc1→3αGal1→4βGal1→4βGlc). Based on experiments involving
choline-independent mutants and different growth conditions, we propose here that
HPA recognizes the αGalNAc terminal residues of the cell wall teichoic and lipoteichoic
acids of S. pneumoniae. In addition, experimental evidence showing that pneumococci
can be specifically labeled with HPA when growing as planktonic cultures as well as
in mixed biofilms of S. pneumoniae and Haemophilus influenzae has been obtained.
It should be underlined that pneumococci were HPA-labeled despite of the presence
of a capsule. Although some non-pneumococcal species also bind the agglutinin,
HPA-binding combined with fluorescence microscopy constitutes a suitable tool for
identifying S. pneumoniae and, if used in conjunction with Gram staining and/or other
suitable technique like antigen detection, it may potentially facilitate a fast and accurate
diagnosis of pneumococcal infections.
Keywords: Streptococcus pneumoniae, Forssman antigen, binding lectins, teichoic acids, fluorescence
microscopy
INTRODUCTION
Streptococcus pneumoniae, the pneumococcus, is a leading human pathogen and one of the
foremost etiologic agents of invasive diseases such as bacteremic community-acquired pneumonia
(CAP), bacteremia, and meningitis, mainly in children, the elderly, and immunocompromised
patients. Indeed, the pneumococcus is one of the major causes of non-invasive diseases such as
non-bacteremic CAP, acute otitis media, sinusitis and conjunctivitis. In 2015, CAP accounted for
16% of all deaths of children under 5 years old globally and 920,000 deaths globally in children of all
ages (World Health Organization, 2016). S. pneumoniae is the commonest bacterial causative agent
across all ages, accounting for 30–40% of CAP cases (Haq et al., 2017). Other bacterial causes of CAP
include Streptococcus pyogenes (group A streptococci; GAS), and Streptococcus agalactiae (group B
streptococci; GBS) in infants. Staphylococcus aureus is associated with round pneumonia, a well-
defined round area of consolidation visible on chest radiographs. Despite the current vaccination
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programs, Haemophilus influenzae remains prevalent in several
developing countries (Hajjeh et al., 2013) and Mycoplasma
pneumoniae accounts for up to a third of all cases and is a
common cause of atypical CAP.
Since mortality rates are highest during the first days of
admission (Ewig et al., 2009), early diagnosis and treatment may
have a crucial role in curing the patient or in reducing their
morbidity and mortality, particularly in the era of antibiotic
resistance (Vila et al., 2017). Rapid identification techniques
are even more important in bacterial meningitis patients, since
delayed initiation of antibiotic treatment is strongly associated
with death and poor outcome; as a consequence, it has
been recently recommended that antibiotic treatment in these
patients should be started as soon as possible, and the time
period from entering the hospital to initiation of antibiotic
treatment should not exceed 1 h (van de Beek et al., 2016).
In every case, the gold standard diagnostic method is still
culture. Unfortunately, this is time consuming (24–72 h) and
includes the inoculation of appropriate media, subculturing, and
phenotype-based characterization via biochemical testing, along
with antibiotic susceptibility testing. Currently, bacteriological
diagnosis is making progress in molecular biology techniques
such as PCR, matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS), and whole
genome sequencing (Clark, 2015; Pai et al., 2015; McGill
et al., 2016; Torres et al., 2016). These techniques have
been developed to decrease the time for the initiation of an
optimal antimicrobial therapy for improving clinical outcomes.
Unfortunately, although microbiological diagnosis is very
important for a correct clinical management of the disease—
particularly because spreading of antibiotic multiresistance is
an increasing global concern—, microbiological identification
is lacking in many instances approaching 50% in CAP cases
(Cilloniz et al., 2016).
Most bacteria in nature exist in multispecies communities
known as biofilms. Multispecies biofilms are structured and
spatially defined communities where species interact both intra-
and interspecifically (Røder et al., 2016). Imaging techniques
are useful for identifying multiple species, which provides
information on their spatial organization. Fluorescence in situ
hybridization (FISH) and many advanced versions of the
FISH technique have been implemented for different purposes;
these are well-established means of visualizing and identifying
microbial groups or species in natural and artificially created
multispecies biofilms (Amann and Fuchs, 2008; Liu et al.,
2016; Røder et al., 2016). Although FISH is typically time-
consuming and destructive to the samples, it is however possible
to visualize different species simultaneously (Schimak et al.,
2016). Fluorescence imaging of individual species can also be
achieved by genetically marking the species with genes coding
for different fluorescent or bioluminescent proteins (Kjos et al.,
2015). Unfortunately, not all bacteria can be fluorescently tagged,
particularly those from natural samples.
Polymicrobial biofilms are abundant in clinical diseases
such as acute otitis media, a significant public health problem
worldwide (Monasta et al., 2012), particularly among children
(Ahmed et al., 2014). Acute otitis media is preceded by
the nasopharyngeal carriage of bacterial pathogens like S.
pneumoniae, non-typeable (NT) H. influenzae, and Moraxella
catarrhalis (Ngo et al., 2016). Moreover, the concurrent
carriage of these pathogens is a predictor of clinical pneumonia
(Chochua et al., 2016). When growing in an in vitro mixed
biofilm, S. pneumoniae and NT H. influenzae cells appear
to accomplish a strong inter-population cooperation, i.e.,
metabolic interdependence or mutualism (Momeni et al., 2013),
as indicated by the finding that pneumococci were intermixed
with NT H. influenzae cells throughout the biofilm (Domenech
and García, 2017). This was determined using the Helix pomatia
(edible snail) agglutinin (HPA) that unambiguously stained
S. pneumoniae cells in themixed biofilms. The binding preference
of HPA has been reported to be the Forssman pentasaccharide
(αGalNAc1→3βGalNAc1→3αGal1→4βGal1→4βGlc)
>blood group A substance (αGalNAc1→3[αFuc1→2]Gal]
>Tn antigen (αGalNAc-Ser/Thr) >GalNAc >GlcNAc,
confirming its specificity for terminal αGalNAc residues
(Wu and Sugii, 1991; Cooling, 2015). The Forssman antigen
(FA) can be defined as a substance that provokes the
appearance of sheep red blood cell hemolytic antibodies
when injected into rabbits; it is a glycolipid with the structure
GalNAcα1→3GalNAcβ1→3Galα1→4Galβ1→4Glcβ1→1Cer
(Siddiqui and Hakomori, 1971). Originally found in the tissues
of different animals (although not humans; Yamamoto et al.,
2012), FA was subsequently discovered in some bacteria,
including S. pneumoniae (Jenkin, 1963). It has been shown
that the Forssman cross-reactive material of S. pneumoniae is
the type IV, ribitol phosphate-containing, membrane anchored
lipoteichoic acid (pnLTA) (Briles and Tomasz, 1973; Gisch
et al., 2013). The non-lipid terminus of pnLTA consists of
6-O-PCho-α-D-GalpNAc-(1→3)-6-O-PCho-β-D-GalpNAc (Seo
et al., 2008); this disaccharide represents a structural feature that
is able to partly explain the FA properties of pnLTA (Gisch et al.,
2013). In addition and unlike other bacterial species, pnLTA
and the S. pneumoniae peptidoglycan-bound teichoic acid
(pnWTA) have identical chain structures (for a recent review,
see reference by Gisch et al. (2015a). Based on this information
it can be assumed that HPA binds to both WTA and LTA of
S. pneumoniae.
In the present study we report that HPA binds to the teichoic
acids (TA) of encapsulated and non-encapsulated pneumococcal
cells grown either planktonically or forming biofilms. In addition
to S. pneumoniae, HPA labeling of other bacterial species, e.g.,
some S. aureus strains, has also been observed. We propose that,
in combination with other widespread rapid techniques, labeling
with HPA in biological fluids may represent a helpful technique
for the fast and accurate diagnosis of pneumococcal diseases.
MATERIALS AND METHODS
Bacteria and Growth Conditions
The bacteria used in this study are listed in Table 1. Streptococci,
staphylococci, enterococci, and Pseudomonas aeruginosa were
grown in Todd-Hewitt broth supplemented with 0.5% yeast
extract (THY). For planktonic growth, the NT H. influenzae
strain 54997 was incubated in brain heart infusion (BHI)
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TABLE 1 | Bacterial strains used in this study.
Strain Description Source or
Referencesa
HPA labelingb
S. pneumoniae
D39 Serotype 2; clinical isolate Lanie et al., 2007 +
P007 Serotype 3; laboratory transformant Domenech et al., 2009 +
R6 Non-encapsulated D39 derivative Hoskins et al., 2001 +
MNZ67 Non-encapsulated; clinical isolate Park et al., 2012 +
1001 Serotype 3; clinical isolate J. Liñaresc +
2951/13 Serotype 12F; clinical isolate Domenech et al., 2015 +
Tupelo_VT Serotype 14; clinical isolate Moscoso et al., 2010 +
1064 Serotype 19F; clinical isolate A. Fenolld +
1178/17 Serotype 22F; clinical isolate L. Viciosod +
2971/13 Serotype 23B; clinical isolate Domenech et al., 2015 +
JY2190 Choline-independent Rx1 mutant; non-encapsulated Yother et al., 1998 +
P501 Choline-independent R6 mutant; non-encapsulated González et al., 2008 +
Streptococcus pseudopneumoniae
CCUG 49455 Type strain CCUG –
Streptococcus mitis
NCTC 12261 Type strain NCTC –
SK137 Biovar 1; strain with choline-containing teichoic acids Bergström et al., 2000 +
SK598 Biovar 1; strain with ethanolamine-containing teichoic acids Bergström et al., 2003 –
Streptococcus oralis
NCTC 11427 Type strain Kilpper-Bälz et al., 1985 –
Streptococcus pyogenes
CECT 985 Type strain; Lancefield group A CECT –
Streptococcus agalactiae
CECT 183 Type strain; Lancefield group B CECT –
Streptococcus dysgalactiae subsp. equisimilis
CECT 926 ATCC 9542; Lancefield group C CECT +
Streptococcus suis
298 Serotype 9; Lancefield group De A. I. Velaf +/–
357 Serotype 2; Lancefield group D A. I. Vela +/–
Staphylococcus aureus
CECT 86 Type strain Shiroma et al., 2015;
CECT
+
15981 Clinical isolate; good biofilm former Valle et al., 2003 +
Staphylococcus epidermidis
CECT 231 Good biofilm former Domenech et al., 2011;
CECT
–
Enterococcus faecalis
CECT 481 Type strain CECT –
Haemophilus influenzae
54997 Nontypeable García-Cobos et al.,
2014
–
Pseudomonas aeruginosa
PAO1 ATCC 15692 ATCC –
aATCC, American Type Culture Collection; CECT, Colección Española de Cultivos Tipo; CCUG, Culture Collection, University of Göteborg; NCTC, National Collection of Type Cultures.
b
+, positive; −, negative; +/−, slightly positive.
c Instituto de Investigación Biomédica de Bellvitge (IDIBEL); Barcelona (Spain).
dLaboratorio de Referencia de Neumococos; Centro Nacional de Microbiología (CNM-ISCIII); Majadahonda (Madrid; Spain).
eAlthough early studies reported that some strains of S. suis contained streptococcal group D antigen, more recent results indicated that the group R and group D antigens were similar
and crossreacted. To date, the species belonging to the Streptococcus bovis group constitute the non-enterococcal group D streptococci (Dekker and Lau, 2016).
fFacultad de Veterinaria; Universidad Complutense de Madrid; Madrid (Spain).
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supplemented with haemin and NAD (15µg/ml each) (sBHI).
In some experiments, S. pneumoniae was grown in C medium
(Lacks and Hotchkiss, 1960) supplemented with 0.08% yeast
extract (Difco Laboratories; C+Y medium) or a chemically
defined medium (Cden) supplemented (or not) with either
choline (5µg/ml) (Cden-choline) or ethanolamine (40µg/ml)
(Cden-EA) (Tomasz, 1968). Cells were incubated at 37◦Cwithout
shaking. Bacterial growth was monitored by measuring the
absorbance at 595 nm (A595).
Formation of mixed biofilms of S. pneumoniae and NT
H. influenzae was performed as described elsewhere (Domenech
and García, 2017). Briefly, cultures of S. pneumoniae strain R6
and H. influenzae strain 54997 were grown to mid-exponential
phase in C+Y medium supplemented with haemin and NAD
(15µg/ml each) [s(C+Y)], diluted to ≈5 × 106 colony-forming
units (cfu)/ml and mixed in an 1:1 proportion. Two milliliter
of the mixtures were then distributed into the wells of a
glass-bottomed dish (WillCo-dish, WillCo Wells B. V., The
Netherlands) and incubated for 6 h at 37◦C under 5% CO2. For
species biofilm formation, 2ml of the individual cultures (5× 106
cfu/ml each) were independently inoculated as indicated above
for mixed biofilms.
All studies which involved the handling of virulent bacteria,
whole blood, or blood derivatives were undertaken at the
biosafety level II laboratory of Centro de Investigaciones
Biológicas. It should be mentioned that, according to the supplier
(Innovative Research), the whole human blood used had been
tested by FDA-approved methods for human immunodeficiency
virus RNA, antibodies to immunodeficiency virus, antibodies
to hepatitis C virus, hepatitis C virus RNA, hepatitis B virus,
hepatitis B surface antigen, and syphilis.
Staining with HPA Lectin
Exponentially growing cells of various bacterial species were
centrifuged, washed and suspended in phosphate-buffered saline
(PBS). After incubation for 15 min at room temperature in
the dark with HPA lectin conjugated to Alexa Fluor-488 (2.5–
25µg/ml), cells were centrifuged again and resuspended in PBS.
Bacteria were observed under a Leica DM4000B fluorescence
microscope equipped with an L5 filter (bandpass 480/40), and
viewed under a Leica HCX PL FLUOTAR 40×/0.75 objective or
anHC PLAPO 63×/1.40–0.60 oil objective. In early experiments,
bacteria were also diluted into fetal bovine serum (from Sigma-
Aldrich), or into defibrinated sheep blood (from Biomedics or
Oxoid). Afterwards, experiments were also carried out with
groups A and O citrated human whole blood (from Innovative
Research). It should be underlined that since HPA labeling does
not require the presence of divalent cations (Kobayashi et al.,
2014), blood treated to prevent its coagulation (e.g., citrate- or
EDTA-treated) can be used.
For biofilm observation, the culture medium was removed
and the biofilm rinsed with sterile water to remove non-adherent
bacteria. Staining was performed with HPA and SYTO 59
and biofilms were gently rinsed with PBS. Observations were
made using a Leica TCS-SP2-AOBS-UV confocal laser scanning
microscope (CLSM) equipped with an argon ion laser. Images
were analyzed using LCS software from Leica. Projections were
obtained in the planes x–y (individual scans at 0.5µm intervals)
and x–z (images at 5µm intervals).
RESULTS
HPA Binding by Different Bacteria
Pneumococci were clearly labeled with HPA when this was
present in concentrations of 2.5–25µg/ml (Figure 1). Closer
examination showed that HPA labeling was not uniform
across the pneumococcal surface; reduced fluorescence was
noticed in the equatorial zone of growth, the place where
new cell wall material is incorporated (Gisch et al., 2015a).
The ability to bind HPA was not exclusive to pneumococci;
the surfaces of other bacteria too were labeled with the
lectin, i.e., Streptococcus mitis SK137 and some strains of
Streptococcus dysgalactiae subsp. equisimilis, Streptococcus suis
and S. aureus (Figure 2, Table 1). Notably, HPA was unable to
label the type strains (T) of Streptococcus pseudopneumoniae,
S. mitis, or Streptococcus oralis, the three closest relatives of
the pneumococcus. Notably, cells of other relevant pathogens,
either Gram-positive (GAS, GBS, Enterococcus faecalis and
Staphylococcus epidermidis) or Gram-negative (H. influenzae
and P. aeruginosa), did not bind the lectin (Table 1). Besides,
and in agreement with previous results (Domenech and
García, 2017), S. pneumoniae (but not NT H. influenzae)
were also labeled with HPA when growing as mixed biofilms
(Figure 3).
FIGURE 1 | Fluorescent labeling of the non-encapsulated S. pneumoniae
strain R6 with HPA. Exponentially growing cultures of S. pneumoniae R6 in
C+Y medium were incubated with the indicated concentrations of the lectin
and observed for fluorescence (HCX PL FLUOTAR 40×/0.75 objective).
Merges of fluorescence and phase-contrast images are also shown; bar =
25µm. Enlarged view of two diplococci showing reduced fluorescence at the
equatorial zone of growth (indicated by arrows; 63× objective). Bar = 2µm.
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FIGURE 2 | HPA labeling of various streptococci in C+Y medium. First row: S. pneumoniae strains R6 (non-encapsulated) (A), D39 (serotype 2) (B), and P007
(serotype 3) (C). Second row: S. suis 298 (D), S. dysgalactiae subsp. equisimilis CECT 926 (E), and S. aureus type strain (F). Bar = 25µm.
FIGURE 3 | S. pneumoniae labeling with HPA in mixed biofilms. (A) Fluorescent labeling of the S. pneumoniae (Sp) strain R6 and the non-typeable H. influenzae
(NTHi) 54997 with HPA. Biofilms formed by Sp R6 or NTHi 54997 (B), or both pathogens (C) were stained with a combination of SYTO 59 (red) and HPA conjugated
to Alexa Fluor-488 (pink). An orthogonal projection of a CLSM image showing a representative region of the x–y plane over the depth of the biofilm in both x–z and y–z
dimensions of the mixed biofilm is also shown at the bottom right part of the figure. Planktonic and biofilms cultures were incubated with HPA (25µg/ml). Bar = 25µm.
The presence of the capsule does not appear to hinder
HPA binding to the S. pneumoniae surface since strains D39
(serotype 2) and P007 (a heavily encapsulated serotype 3
transformant) were efficiently labeled (Figures 2B,C). Cells of
S. pneumoniae D39 were also positive for HPA binding when
diluted to 2.5 × 106 cfu/ml into defibrinated sheep blood or
into fetal bovine serum, although excess fluorescence on the
erythrocyte surface may partly hinder a distinct pneumococcal
identification (Figure 4). As HPA also binds to the human
blood group A antigen (Matsui et al., 2001), that interference,
which is due to the fact that sheep erythrocytes harbor FA on
their surface (see above), should disappear using group non-A
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FIGURE 4 | HPA labeling of S. pneumoniae in non-human blood and serum. The type 2 encapsulated S. pneumoniae strain D39 was diluted to 2.5 × 106 cfu/ml into
sheep blood or fetal bovine serum (63× objective). Cultures were incubated with HPA (25µg/ml). Arrows point to pneumococcal cells. Bar = 25µm.
(e.g., group O) human whole blood. In addition, it should be
mentioned that up to 98 pneumococcal capsular polysaccharides
differing in sugar composition and linkages have been described
to date (Geno et al., 2017). Besides, invasive pneumococcal
disease and pneumonia rates have decreased in most countries
following the introduction of conjugate pneumococcal vaccines
(PCVs). However, after PCV implementation, current data
show that more non-vaccine serotypes increased in frequency
than decreased, which is consistent with vaccine-induced
replacement. Clinical pneumococcal isolates of six different
serotypes—including three emerging serotypes that are currently
among the predominant non-PCV13 serotypes worldwide,
i.e., serotypes 12F, 22F, and 23B; Balsells et al., 2017)—were
diluted to about 2.5 × 106 cfu/ml into whole human blood,
incubated with HPA, and observed under the microscope.
Moreover, due to the increasing clinical importance of non-
encapsulated S. pneumoniae (Keller et al., 2016), a representative
strain (MNZ67) was also investigated. All the pneumococcal
isolates tested bound the lectin and, as expected, HPA-labeled
pneumococci were particularly noticeable using group O human
blood (Figure 5). It is worth mentioning that any possible
interference caused by an excess fluorescence on the surface of
group A human erythrocytes could be virtually abolished by
partly sedimenting the blood cells at low speed (1,000× g; 1 min;
room temperature) before HPA addition (Figure 5A, bottom
right).
HPA Labeling of Pneumococcal Teichoic
Acids
With the possible exception of S. pseudopneumoniae (González
et al., 2008), the nutritional requirement of pneumococci for
the amino alcohol choline (as a component of pnWTA and
pnLTA) appears to be an exclusive trait (Rane and Subbarow,
1940). Nevertheless, several choline-independent pneumococcal
mutants have been characterized in the last years, and it has been
suggested that the absence of choline incorporation might affect
the structure of TAs as well as the composition of the cell wall.
Actually, it has been shown that pnLTA and pnWTA isolated
from these mutants were free of phosphocholine and other
phosphorylated aminoalcohols (Yother et al., 1998). However,
and as deduced from the in vivo cell labeling with HPA of two
double tacF mutants that form long chains of cells (and are
autolysis-defective) when grown in media lacking any amino
alcohol (strains JY2190 and P501), the absence of choline residues
in TAs does not appear to modify HPA binding by S. pneumoniae
(Figure 6).
It is well known that pneumococci growing in Cden medium
containing EA instead of choline form long chains, do not
autolyze, and are non-transformable (Tomasz, 1968). In the
present work, the EA-grown cells were unable to bind HPA
(Figures 7A,D). The same was seen when S. pneumoniae
R6 was incubated in C+Y supplemented with 2% choline
chloride (data not shown). It has been reported that upon
the addition of choline (5µg/ml) to EA-grown pneumococci,
these cells revert to the normal phenotype (Tomasz et al.,
1975). As expected, EA-grown cells became entirely HPA-
labeled 180 min (≈4 generations) after shifting to a choline-
containing medium (Figures 7B,E). As an alternative and
complementary model, we examined the S. mitis strain SK598,
which is unique in that its WTA and LTA contain EA
instead of choline even when incubated in a choline-containing
medium (Bergström et al., 2003). As observed for EA-grown
S. pneumoniae cells, S. mitis SK598 was unable to bind HPA
(Figures 7C,F).
DISCUSSION
In a previous work we have shown that, in contrast to
S. pneumoniae, NT H. influenzae strains did not bind HPA;
thus fluorescent staining of S. pneumoniae with the HPA lectin
revealed that pneumococci were evenly distributed throughout
the in vitro biofilm and interspersed with NT H. influenzae
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FIGURE 5 | HPA labeling of clinical pneumococcal isolates in human blood. The S. pneumoniae strains were diluted to 2.5 × 106 cfu/ml into group O (A) and A (B)
human blood (40× objective). Serotypes are indicated in parentheses. Strain MNZ67 is a non-encapsulated clinical isolate. In (A), the images shown at the bottom
right are enlarged visions of the area marked with a rectangle in strain 1001. Control denotes non-infected blood samples. In (B), those labeled with an asterisk
correspond to views of the supernatant of infected group A blood that had been centrifuged (1,000 × g; 1 min; room temperature) before HPA labeling. Samples were
incubated with HPA (25µg/ml). The arrow points to a pneumococcal diplococcus. Phc, phase-contrast micrograph; Bar = 25µm.
(Domenech and García, 2017). We have shown here that HPA
recognition of the S. pneumoniae surface does not require
the presence of choline residues in TAs. This observation is
in agreement with the results of Gisch et al. who recently
reported that the presence/absence of phosphorylcholine in the
FA terminus of pnLTA to have no effect on detection by an anti-
Forssman antibody (Gisch et al., 2013). This is relevant since the
number of repeating units and the phosphocholine content per
repeat (mono-substituted or di-substituted) for pneumococcal
TAs slightly vary among strains (Gisch et al., 2015a). It is
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interesting, however, that, in the present work, EA-grown cells
or S. pneumoniae R6 incubated in C+Y supplemented with 2%
choline chloride did not bind HPA. Incubation in high choline
concentrations inhibits cell separation, leaving pneumococci to
grow in long chains of cells, just like EA-grown cells (Briese and
Hakenbeck, 1984; Giudicelli and Tomasz, 1984). This phenotype
is, at least partly, the result of the inhibition of LytB—a member
of the family of choline-binding proteins (CBPs)—and the release
of this and other CBPs to the medium (López and García,
2004). Both processes would be expected to occur in choline-
independent strains growing in the absence of any amino alcohol
(see above), although when this was performed in the present
work HPA-labeling was unaffected. Interestingly, in an early
study, Briles and Tomasz reported the yield of heterophile
(sheep hemolytic) antibodies elicited by pneumococci to be at
least 10-fold greater in choline- than in EA-containing media
(Briles and Tomasz, 1975). Moreover, these authors reported that
pneumococci growing in C+Y medium (choline-containing)
elicit antibodies which bind poorly to EA-grown bacteria,
whereas the latter elicit antibodies which bind well to choline-
grown cells. The reasons for these unexpected results are still
unclear, although the possibility of the existence of a choline-
dependent regulatory pathway for the synthesis of pneumococcal
TAs warrants future research.
To our knowledge, the concentration of free choline (or EA) in
human lungs has not been reported so far. However, the normal
levels of free choline and EA in human fluids are quite similar,
e.g., about 1µM each in serum (Forteschi et al., 2016; Derezin´ski
et al., 2017) and 2µM for choline or 9–15µM for EA in
cerebrospinal fluid (CSF) (Kruse et al., 1985; Frölich et al., 1998;
Ogawa et al., 2015). These data together with the early findings
that choline is an effective inhibitor of the cellular incorporation
of EA: addition of as little as 0.1µg/ml choline to a culture
growing in the presence of 40µg/ml EA immediately inhibited
further EA incorporation, and that choline was incorporated by
such cultures without any detectable lag (Tomasz, 1968), strongly
suggest that EA-grown cells (or pneumococci grown in high
choline concentrations) are not expected to be found in nature,
although they represent important model systems for in vitro
studies.
HPA labeling allows the recognition of S. pneumoniae cells
among a variety of other species. However, it is clear that
HPA specificity is not restricted to pneumococci (Table 1).
Interestingly, neither S. pseudopneumoniaeT, S. mitisT nor
S. oralisT binds the lectin; this is of note since, although
these three species are very closely related to S. pneumoniae,
monoclonal antibodies directed against the backbone and the
phosphocholine residues of TAs react only with some strains
of these three species (Kilian et al., 2008). The binding of
HPA to these bacteria could, therefore, be mostly strain-
specific. For example, in contrast to that observed for S. mitisT,
S. mitis SK137 was susceptible to HPA labeling (Table 1). This
was not unexpected since this particular strain has choline-
containing TAs with a carbohydrate backbone identical to that
of pnWTA/pnLTA, which forms the Lancefield group O antigen
(Bergström et al., 2000). Quite unexpectedly, the SK137 strain
only showed an average 67.1% nucleotide similarity to the
FIGURE 6 | HPA labeling of two choline-independent S. pneumoniae strains.
Pneumococcal strains JY2190 (A,B) and P501 (C,D) were incubated in a
chemically-defined medium (Cden) lacking any amino alcohol, and labeled with
HPA (25µg/ml). Bar = 25µm.
S. mitisT in a DNA–DNA hybridization assay (Kilian et al., 2008),
slightly below the 70% level typically expected for two strains
of the same species (Wayne et al., 1987). Whether strain SK137
represents a distinct species is, however, debatable, according to
recent taxonomic proposals (Tindall et al., 2010).
The type strain of S. oralis (NCTC 11427)—the LTA structure
of which is unknown—did not bind HPA (Table 1). However, a
recent study has revealed that, in contrast to pnLTA, in which
the structural element αGalNAc1→3βGalNAc1→ is present
(Gisch et al., 2013), only a βGalNAc1→ moiety is detectable
in the S. oralis Uo5 LTA repeating unit (Gisch et al., 2015b).
Assuming an identical LTA structure for S. oralisT, the lack of the
αGalNAc1→ residue at the non-reducing end would fit in with
the absence of HPA labeling. It should be underlined that at least
three biochemical variants of choline-containing TAs may occur
in S. oralis and some S. mitis strains, according to recent results
(Denapaite et al., 2016).
Among the few other bacterial species tested, Lancefield group
C and D streptococci were positive for HPA labeling. These
results were expected in view of previous reports of Streptococcus
belonging to groups C (Coligan et al., 1977; Sørensen and
Henrichsen, 1987; Köhler and Nagai, 1989) and D (Kurl et al.,
1989). From a diagnostic perspective, however, it is important
to underline that non-pneumococcal, viridans (i.e., α-hemolytic)
streptococci are usually considered as commensals and seldom
cause CAP. It is well known that viridans streptococci produce a
range of invasive disease in humans (e.g., infective endocarditis)
and are also emerging as a cause of bloodstream infections, but
mainly in immunocompromised patients (Doern and Burnham,
2010). S. dysgalactiae subsp. equisimilis, which belongs to the β-
hemolytic group C and G pyogenic group of streptococci, also
binds HPA and is also currently considered as an emergent
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FIGURE 7 | Lack of HPA labeling in ethanolamine-containing streptococci. S. pneumoniae R6 cells were incubated for several generations in Cden medium
containing ethanolamine (Cden-EA) (A,D). A portion of the culture then received choline chloride (5µg/ml) and incubation proceeded at 37◦C for 3 h (B,E). The
S. mitis SK598 strain was grown in THY medium (C,F). The three cultures were incubated with HPA (25µg/ml) (D–F). Bar = 25µm.
human pathogen. Nevertheless, and as mentioned above for
viridans streptococci, it is a frequent cause of invasive disease
only in patients having underlying conditions (Broyles et al.,
2009).
S. aureus is an important opportunistic pathogen that
persistently colonizes about 20% of the human population
and is intermittently associated with the remainder. This
organism is one of the most frequent and important human
pathogens and is implicated in a range of infections, including
superficial skin infections, abscesses, and food poisoning as
well as life-threatening invasive diseases (Tong et al., 2015).
Although, S. aureus possesses surface carbohydrates that might
be recognized by HPA (Krivan et al., 1988; Payne et al., 1992),
the molecular basis for HPA binding is not well understood.
It has been shown, however, that certain methicillin-susceptible
S. aureus isolates—in particular those belonging to the atypical
sequence type (ST) 395 lineage (e.g., strain PS187; Winstel et al.,
2013)—produce a glycerol TA modified with αGalNAc (Winstel
et al., 2014; Lee et al., 2015) that may be responsible for HPA
binding. It should be noted, however, that the chemical structures
of WTA and LTA of S. aureus are similar but not identical (Xia
et al., 2010; Brown et al., 2013), that the ST of the type strain of
S. aureus (ST8) is only distantly related to ST395, and that strain
PS187 appears to be more closely related to several coagulase-
negative staphylococcal species than to other S aureus isolates
(Winstel et al., 2013); the ST of S. aureus 15981 is unknown.
It has been demonstrated that staphylococci can be accurately
differentiated from streptococci in Gram-stained preparations
(cocci in clusters and diplococci or short chains, respectively;
Agger and Maki, 1978), and that S. aureus is more uncommon
than the latter in CAP and acute meningitis cases. However, our
results warrant additional studies to determine whether HPA
labeling is common among S. aureus isolates, particularly in
methicillin-resistant isolates that represent a global health care
problem (Tong et al., 2015).
In agreement with a previous report (Domenech and
García, 2017), NT H. influenzae strains did not bind HPA;
identical results are shown here for P. aeruginosa PAO1.
Together with S. pneumoniae, both Gram-negative species are
common in biofilms formed during acute otitis media and
live-threatening, chronic respiratory diseases such as chronic
obstructive pulmonary disease or cystic fibrosis (Blasi et al.,
2016). The use of HPA as S. pneumoniae-specific lectin for
fluorescence imaging should provide a powerful tool for future
research on these and other relevant human pathogens forming
multispecies biofilms.
HPA labeling combined with Gram staining and/or antigen
detection may also constitute an appropriate combination for
the rapid diagnosis of CAP and, perhaps, other conditions such
as bacterial meningitis (McGill et al., 2016). This may facilitate
the rapid implementation of an appropriate antibiotic regime,
which is conditional on the age of the patient and the regional
rate of decreased susceptibility of S. pneumoniae to β-lactam
antibiotics (van de Beek et al., 2016). As a proof of concept,
cultures of pneumococci, H. influenzae and GBS were mixed
either with sheep blood or fetal bovine serum. Also using human
whole blood, only pneumococci (either encapsulated or non-
encapsulated) were clearly identified by HPA labeling when used
at a relatively low bacterial concentration (2.5× 106 cfu/ml). This
concentration is lower than that frequently found in the blood of
CAP patients (between 7× 107 and 8× 108 cfu/ml; Gadsby et al.,
2016) or in the CSF of children with confirmed pneumococcal
meningitis (median bacterial load ≈5 × 107 DNA copies/ml)
at the time of admittance (Roine et al., 2009). If required,
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bacteria could be concentrated by centrifugation before or after
staining.
There are a number of limitations to our study: (1) although
the HPA labeling technique does not require a very specialized
personnel, fluorescence microscopy may be unavailable in
many laboratories of developing countries. To circumvent
this problem, biotinilated HPA, and alkaline phosphatase- or
ferritin-conjugated HPA could be employed. (2) Only seven
different bacterial genera—including 15 streptococcal and 3
staphylococcal strains—, were tested. It should be noted,
however, that the bacteria tested here include some of the
microorganisms most frequently causing CAP and other severe
diseases. (3) Although pneumococci and staphylococci are
morphologically different, the finding that two S. aureus strains
also bind HPA may sometimes represent a diagnostic drawback
and deserves further research. It should be noted, however, that,
for example, severe sepsis—a serious complication of CAP—
is caused by S. pneumoniae about 100 times more frequently
than by S. aureus, whereas methicillin-resistant S. aureus is
an important cause of antimicrobial-resistant hospital-acquired
infections worldwide and remains a public health priority in
Europe (Montull et al., 2016). (4) This represents an in vitro study
and an appropriate evaluation of the benefits of HPA labeling for
diagnostic purposes should be performed directly with clinical
samples, e.g., sputum, brochoalveolar fluid, blood, and/or CSF.
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